Foghorn Therapeutics Inc. Increase (Decrease) in Accounts Payable
Foghorn Therapeutics Inc. (FHTX) reported Increase (Decrease) in Accounts Payable of -$1.06 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2026-08-06
- Foghorn Therapeutics Inc. increase (decrease) in accounts payable for the quarter ending 2026-06-30 was -$69.00K.
- Foghorn Therapeutics Inc. increase (decrease) in accounts payable for the quarter ending 2026-03-31 was -$990.00K, a 448.59% decline year-over-year.
- Foghorn Therapeutics Inc. increase (decrease) in accounts payable for the quarter ending 2025-12-31 was $1.05M, a 215.57% increase year-over-year.
- Foghorn Therapeutics Inc. increase (decrease) in accounts payable for the quarter ending 2025-09-30 was -$110.00K.
- Foghorn Therapeutics Inc. increase (decrease) in accounts payable for fiscal 2025 was $481.00K.
- Foghorn Therapeutics Inc. increase (decrease) in accounts payable for fiscal 2024 was -$2.48M, a 392.55% decline from fiscal 2023.
- Foghorn Therapeutics Inc. increase (decrease) in accounts payable for fiscal 2023 was $846.00K, a 47.58% decline from fiscal 2022.
- Foghorn Therapeutics Inc. increase (decrease) in accounts payable for fiscal 2022 was $1.61M, a 1095.56% increase from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$69.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$1.06M 10-Q · filed 2026-08-06 | -$5.00K derived: sum of 3 quarters · filed 2026-08-06 | -$115.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | -$990.00K 10-Q · filed 2026-05-07 | $64.00K derived: sum of 2 quarters · filed 2026-05-07 | -$46.00K derived: sum of 3 quarters · filed 2026-05-07 | -$793.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $1.05M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-11 | $944.00K derived: sum of 2 quarters · filed 2026-03-11 | $197.00K derived: sum of 3 quarters · filed 2026-08-06 | $481.00K 10-K · filed 2026-03-11 |
| 2025-09-30 | -$110.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$857.00K derived: sum of 2 quarters · filed 2026-08-06 | -$573.00K 10-Q · filed 2025-11-05 | -$239.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | -$747.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$463.00K 10-Q · filed 2026-08-06 | -$129.00K derived: sum of 3 quarters · filed 2026-08-06 | -$1.48M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $284.00K 10-Q · filed 2026-05-07 | $618.00K derived: sum of 2 quarters · filed 2026-05-07 | -$733.00K derived: sum of 3 quarters · filed 2026-05-07 | -$1.56M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $334.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-11 | -$1.02M derived: sum of 2 quarters · filed 2026-03-11 | -$1.85M derived: sum of 3 quarters · filed 2026-03-11 | -$2.48M 10-K · filed 2026-03-11 |
| 2024-09-30 | -$1.35M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$2.18M derived: sum of 2 quarters · filed 2025-11-05 | -$2.81M 10-Q · filed 2025-11-05 | -$3.04M derived: sum of 4 quarters · filed 2025-11-05 |
| 2024-06-30 | -$829.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | -$1.46M 10-Q · filed 2025-08-05 | -$1.69M derived: sum of 3 quarters · filed 2025-08-05 | -$2.13M derived: sum of 4 quarters · filed 2025-08-05 |
| 2024-03-31 | -$629.00K 10-Q · filed 2025-05-14 | -$865.00K derived: sum of 2 quarters · filed 2025-05-14 | -$1.30M derived: sum of 3 quarters · filed 2025-05-14 | -$1.47M derived: sum of 4 quarters · filed 2025-05-14 |
| 2023-12-31 | -$236.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | -$674.00K derived: sum of 2 quarters · filed 2025-03-06 | -$845.00K derived: sum of 3 quarters · filed 2025-03-06 | $846.00K 10-K · filed 2025-03-06 |
| 2023-09-30 | -$438.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-04 | -$609.00K derived: sum of 2 quarters · filed 2024-11-04 | $1.08M 10-Q · filed 2024-11-04 | $1.24M derived: sum of 4 quarters · filed 2024-11-04 |
| 2023-06-30 | -$171.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $1.52M 10-Q · filed 2024-08-08 | $1.68M derived: sum of 3 quarters · filed 2024-08-08 | $3.30M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $1.69M 10-Q · filed 2024-05-06 | $1.85M derived: sum of 2 quarters · filed 2024-05-06 | $3.47M derived: sum of 3 quarters · filed 2024-05-06 | $2.03M derived: sum of 4 quarters · filed 2024-05-06 |
| 2022-12-31 | $157.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | $1.78M derived: sum of 2 quarters · filed 2024-03-07 | $343.00K derived: sum of 3 quarters · filed 2024-03-07 | $1.61M 10-K · filed 2024-03-07 |
| 2022-09-30 | $1.62M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $186.00K derived: sum of 2 quarters · filed 2023-11-02 | $1.46M 10-Q · filed 2023-11-02 | $1.44M derived: sum of 4 quarters · filed 2023-11-02 |
| 2022-06-30 | -$1.44M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | -$165.00K 10-Q · filed 2023-08-04 | -$186.00K derived: sum of 3 quarters · filed 2023-08-04 | $229.00K derived: sum of 4 quarters · filed 2023-08-04 |
| 2022-03-31 | $1.27M 10-Q · filed 2023-05-08 | $1.25M derived: sum of 2 quarters · filed 2023-05-08 | $1.67M derived: sum of 3 quarters · filed 2023-05-08 | $2.16M derived: sum of 4 quarters · filed 2023-05-08 |
| 2021-12-31 | -$21.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | $394.00K derived: sum of 2 quarters · filed 2023-03-09 | $889.00K derived: sum of 3 quarters · filed 2023-03-09 | $135.00K 10-K · filed 2023-03-09 |
| 2021-09-30 | $415.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $910.00K derived: sum of 2 quarters · filed 2022-11-08 | $156.00K 10-Q · filed 2022-11-08 | $1.00M derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | $495.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | -$259.00K 10-Q · filed 2022-08-09 | $589.00K derived: sum of 3 quarters · filed 2022-08-09 | $500.00K derived: sum of 4 quarters · filed 2022-08-09 |
| 2021-03-31 | -$754.00K 10-Q · filed 2022-05-09 | $94.00K derived: sum of 2 quarters · filed 2022-08-09 | $5.00K derived: sum of 3 quarters · filed 2022-08-09 | -$1.25M derived: sum of 4 quarters · filed 2022-08-09 |
| 2020-12-31 | $848.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2022-08-09 | $759.00K derived: sum of 2 quarters · filed 2022-08-09 | -$495.00K derived: sum of 3 quarters · filed 2022-08-09 | $474.00K 10-K/A · filed 2022-08-09 |
| 2020-09-30 | -$89.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | -$1.34M derived: sum of 2 quarters · filed 2021-11-09 | -$374.00K 10-Q · filed 2021-11-09 | $278.00K derived: sum of 4 quarters · filed 2021-11-09 |
| 2020-06-30 | -$1.25M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10 | -$285.00K 10-Q · filed 2021-08-10 | $367.00K derived: sum of 3 quarters · filed 2021-08-10 | |
| 2020-03-31 | $969.00K 10-Q · filed 2021-05-11 | $1.62M derived: sum of 2 quarters · filed 2021-05-11 | ||
| 2019-12-31 | $652.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-18 | $1.21M 10-K · filed 2021-03-18 | ||
| 2019-09-30 | $559.00K 10-Q · filed 2020-12-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |